The US FDA advises consumers to avoid “chelation” products, over-the-counter (OTC) for prevention or treatment of diseases because they can cause serious harm and/or death. Background of Over-the-Counter Chelation drugs Chelation is used to remove heavy metals from the body via certain chemicals. Some of these products are marketed as dietary supplements but they are [...]
Read more
A safety alert on the combination of Statins, Hepatitis C and HIV drugs has been brought to the attention of medical practitioners in infectious diseases, family practice, as well as patients at large. Medical professionals are hereby being updated of the changes in prescription details when administering combinations of protease inhibitors for either HCV or [...]
Read more09/01/2011 Medical professionals, along with their patients, were notified by the FDA, about an update to the drug label for Reclast (Zoledronic acid). When taking this drug there is a large risk of kidney failure. There have been several cases reported to the FDA about acute renal failure that requires dialysis or fatal outcomes following [...]
Read more06/08/2011 The FDA has issued a healthcare warning to healthcare professionals that it is recommending lowering the dose amount of the medication Simvastatin (80 mg), which is a cholesterol-lowering drug, due to studies that show increased risk of muscle damage. Current patients who are taking the drug Simvastatin 80mg on a daily basis are proven [...]
Read moreThe drug OsmoPrep has been connected with acute kidney injury and kidney failure; anyone who has taken OsmoPrep should consult a doctor or find immediate medical attention if they exhibit any of the following symptoms: Decreased urination Swelling in the ankles, legs, or feet Tingling lips Unexplained or unusual weight gain Dry mouth Dehydration Dizziness [...]
Read more
Recent Comments